When: $900 retest without bullish reversal candle

Then: Further reduce remaining 75%

HOLD with options hedge or trailing stop

• Hold the position rather than trim into a 16% pullback; 200 SMA at $845 has never been tested on this rally and should be the true exit signal, not anticipation
• Forward valuation is more favorable than the aggressive analyst suggests: Q2'26 clean EPS of $2.47 ($10 annualized) with backlog doubled YoY to $39.9B supports $14-18 EPS in 12-18 months, bringing the multiple to ~60x at $990 rather than 100x
• The aggressive analyst's own trading plan is internally inconsistent: a stop at $1,020 above the entry at $1,000 means the trim would trigger re-entry on any bounce rather than protecting against downside
• Recommend hedging with put options (e.g., $900 strike December puts or put spreads) to cap risk while preserving upside participation, rather than selling stock
• Trailing stop should be set at $830-$820 based on structural levels, not react to short-term noise at the 50 SMA
• The July 29 capitulation low at $900 broke the Bollinger lower band but buyers stepped in immediately, recovering to $1,018 by August 4, demonstrating price action finding a base rather than terminal decline

→ vs aggressive: Selling before 200 SMA confirmation is not risk management but market timing; the SMA at $845 is 17% below current price and has never been tested on this rally

BUY (trim 25% of position, fix stop to $960/$950, use dual invalidation framework, hedge with optional put spreads)

• TTM EPS of $34.91 is distorted; clean annualized EPS is ~$9-10 after stripping $4.41B Q1'26 unusual items and $2.57B Q4'25 deferred tax benefit
• Q2'26 FCF of $5.11B is not sustainable; working capital release from deferred revenue doubling YoY will normalize; sustainable FCF is ~$3-5B annually
• Marketed backlog of $176B has $136B of soft commitments, creating legitimate anchoring concern
• Forward clean EPS plausible at $14-16 in 12-18 months if backlog prepayment contracts and buybacks ($9-10B annual run rate, ~1% float per quarter) deliver; still elevated at 60-70x but not 100x
• Balance sheet is fortress: net cash of $10.3B vs $2.8B total debt; downside scenario is multiple compression, not credit event
• 5 consecutive weeks of lower highs/lower lows is a real pattern; price below 10 EMA, 50 SMA, and Bollinger middle; RSI at 46; VWMA resistance at $996; ATR at $58
• 200 SMA at $845 is intact (17% above current price) and has not been tested during entire rally; selling before test historically costs long-term investors
• Structural uptrend intact but near-term asymmetry is genuinely interesting: stretched valuation on clean earnings, fading FCF quality, deteriorating momentum
• Dual invalidation framework recommended: hard exit on 200 SMA break below $845 on elevated volume; position-reduction trigger at $900 without bullish reversal candle
• Put spread at $900/$800 for December at ~4-5% of position value recommended as more efficient hedging than directional stock sales
• Conservative analyst's trailing stop at $830/$820 is too loose given $58 ATR; $50-60 stop from current price is more defensible
• Do not redeploy trimmed capital into GEV on first bounce; let cash sit or rotate to less correlated names

→ vs aggressive: Dot-com and 2008 analogies overreach; current situation is a 16% pullback within structural uptrend after 53% revenue jump over 5 quarters, not a regime change

→ vs aggressive: Stop placement at $1,020 above entry of $1,000 is logically incoherent; triggers buy on upward movement, making it a soft hedge not a directional bet; genuine bear case requires stop below entry

→ vs aggressive: 100x valuation criticism is valid but assumes Q2'26 EPS is permanent earning power; if backlog ($176B, $39.9B deferred revenue) is real, forward EPS trajectory to $14-16 reduces multiple to 60-70x

→ vs conservative: Calling technical pattern 'noise' is too dismissive; 5 weeks of lower highs/lows, MACD below signal, price below multiple averages is genuine deterioration, not noise

→ vs conservative: EPS extrapolation to $14-18 in 12-18 months requires stacked assumptions: margin expansion (7.5% current), aggressive buybacks at elevated prices, and 18 months of clean execution in no-Fed-cuts/macro-moratorium environment

→ vs conservative: $830 trailing stop is too loose for $58 ATR regime; gives back almost all post-spinoff gains if triggered; conflates long-term discipline with appropriate short-term risk management